Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients

NCT07057154 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2025-07-09

No results posted yet for this study

Summary

The aim of this study was to evaluate the impact of GHI and RDW as prognostic indicator in critically ill Patients.

Conditions

  • Critical Ill Patients

Interventions

DEVICE

Hbg and RDW

Hbg and RDW as prognstic indicator in critical ill patients

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-05
Primary Completion
2026-08-29
Completion
2026-12-02

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07057154 on ClinicalTrials.gov